The Liposomal Doxorubicin market was valued at USD 1,240.00 Million in 2022 and is expected to reach USD 1,961.50 Million by 2030, growing at a CAGR of 5.9% (2022-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.